|
2021
|
G/S
|
Pharmaceutical preparations, namely, pharmaceutical preparations for the relief of pain; pharmace... |
|
2020
|
G/S
|
Pharmaceutical preparation for hematopoietic growth factors; pharmaceutical preparation, namely r... |
|
2018
|
G/S
|
Natural and non-prescription health care products, namely, fatty acids for use as additives to fo... |
|
|
Invention
|
Pharmaceutical compositions comprising hydromorphone and naloxone.
Disclosed is a prolonged rele... |
|
2017
|
G/S
|
Opioid antagonist pharmaceutical preparations; pharmaceutical preparations for the treatment of o... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of diseases and disorders of the central nervous sy... |
|
2016
|
G/S
|
Pharmaceutical preparation, namely an analgesic administered transdermally via patches that adher... |
|
|
G/S
|
pharmaceutical substances and preparations for the treatment of pain |
|
|
G/S
|
Preparation for the relief of pain. |
|
2015
|
Invention
|
Methods and compositions particularly for treatment of attention deficit disorder. There is descr... |
|
|
Invention
|
Methods and compositions particularly for treatment of attention deficit disorder.
|
|
|
Invention
|
Reducing drug liking in a subject.
There is described a method of reducing drug liking a subject... |
|
|
Invention
|
Reducing drug liking in a subject. There is described a method of reducing drug liking a subject ... |
|
2014
|
G/S
|
Pharmaceutical preparations for the relief of pain. Providing information to health care provider... |
|
|
G/S
|
Pain-relief tablets for oral consumption formed by a process that hardens the tablets, making the... |
|
2013
|
Invention
|
Pharmaceutical compositions comprising hydromorphone and naloxone.
There is described a prolonge... |
|
|
Invention
|
Pharmaceutical compositions comprising hydromorphone and naloxone. Disclosed is a prolonged relea... |
|
|
Invention
|
Abuse-resistant opioid dosage form.
We provide a pharmaceutical dosage form including an opioid ... |
|
2012
|
Invention
|
Pharmaceutical compositions comprising hydromorphone and naloxone. There is described a pro... |
|
|
Invention
|
Pharmaceutical compositions comprising hydromorphone and naloxone.
There is described ... |
|
2010
|
G/S
|
Tablets for oral consumption formed by a process that hardens the tablets, making them resistant ... |
|
|
G/S
|
Pharmaceutical preparations, namely ophthalmic preparations for the treatment of glaucoma. |
|
|
G/S
|
Analgesic preparation for the relief of pain and preparation for the relief of opioid-induced con... |
|
|
Invention
|
Once-daily oral ir/cr pramipexole formulation.
An oral once-daily pramipexole formulation, compr... |
|
|
Invention
|
Once-daily oral ir/cr pramipexole formulation.
An oral once-daily
pramipexo... |
|
|
Invention
|
Once-daily oral ir/cr pramipexole formulation. An oral once-daily pramipexole formulation, compri... |
|
2009
|
G/S
|
Pharmaceutical preparations, namely, ophthalmic preparations for the treatment of glaucoma. |
|
2006
|
G/S
|
Analgesic preparation for the relief of pain. |
|
|
Invention
|
Dosage form containing oxycodone and naloxone.
The present invention concerns a d... |
|
|
Invention
|
Dosage form containing oxycodone and naloxone.
The present invention concerns a dosage... |
|
2005
|
G/S
|
Pellets or beads consisting of multiple layers of drug and drug release-controlling excipients, w... |
|
2004
|
G/S
|
Opioid pharmaceutical preparation for relief of pain, in capsule or tablet form. |
|
2003
|
Invention
|
Pharmaceutical preparation containing oxycodone and naloxone. The invention concerns a storage st... |
|
2002
|
Invention
|
Abuse-resistant opioid dosage form. The present invention pertains to a pharmaceutical dosage for... |
|
2001
|
G/S
|
Pharmaceutical preparation for relief of pain, in capsule or tablet form. |
|
2000
|
Invention
|
Hydromorphinone and hydrocodeinone compositions and methods for their synthesis.
A met... |
|
|
G/S
|
Pharmaceutical preparation for the relief of pain, in capsule or tablet form. |
|
|
G/S
|
Research and development, production and distribution, sales of pharmaceuticals. |
|
1998
|
G/S
|
Central nervous system (CNS) stimulant. |
|
1997
|
G/S
|
Analgesic preparation. |
|
|
G/S
|
Preparation for relief of pain. |
|
1995
|
G/S
|
Analgesic preparations. |
|
|
G/S
|
Pharmaceuticals, namely, a controlled-release system used as an ingredient in pharmaceutical prep... |
|
|
G/S
|
Pharmaceutical preparation, namely, bronchodilator. |
|
|
G/S
|
Pharmaceutical specialties for human and veterinary use, namely, bronchodilators. |
|
|
G/S
|
Ophthalmic preparations. |
|
1993
|
G/S
|
Controlled release delivery composition for use as a component of pharmaceutical preparations. |
|
1992
|
G/S
|
Medicinal preparation for ophthalmic use. |
|
1990
|
G/S
|
Pharmaceutical preparations for the treatment of disorders of the eye. |
|
1984
|
G/S
|
Pharmaceutical product, namely narcotic analgesic for severe pain.
Pharmaceutical product, namely... |
|
1980
|
G/S
|
Human pharmaceutical preparations for bronchitis, rhinitis, sinusitis, respiratory congestion and... |
|
1978
|
G/S
|
Medicinal preparation for opthalmic use. |
